Ohuchi, K., Kambayashi, Y., Hidaka, T., & Fujimura, T. (2021). Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Ohuchi, Kentaro, Yumi Kambayashi, Takanori Hidaka, y Taku Fujimura. Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Ohuchi, Kentaro, et al. Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients. Frontiers Media S.A, 2021.
Precaución: Estas citas no son 100% exactas.